|
| 36083003 | Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features. | J Natl Cancer Inst | 2023 |
| 37671026 | Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2. | Cell Rep Methods | 2023 |
| 37907613 | The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients. | NPJ Precis Oncol | 2023 |
| 37178002 | Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data. | Nucleic Acids Res | 2023 |
| 36964195 | Prediction model for drug response of acute myeloid leukemia patients. | NPJ Precis Oncol | 2023 |
| 36476658 | Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma. | Br J Cancer | 2023 |
| 36878102 | Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing. | Lung Cancer | 2023 |
| 36464160 | Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates. | SLAS Discov | 2023 |
| 36934951 | Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT). | SLAS Discov | 2023 |
| 36933996 | Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets. | Eur Urol Focus | 2023 |
| 34837846 | High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma. | Transl Oncol | 2022 |
| 35795056 | Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma. | Front Oncol | 2022 |
| 35642679 | Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancerâ¿¿Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling". | J Proteome Res | 2022 |
| 35354797 | Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines. | Nat Commun | 2022 |
| 36874403 | Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer. | Cancer Res Commun | 2022 |
| 36575299 | Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. | NPJ Precis Oncol | 2022 |
| 35977930 | Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention. | Cell Death Dis | 2022 |
| 34890102 | E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. | Mol Oncol | 2022 |
| 34856119 | Multiomics and digital monitoring during lifestyle changes reveal independent dimensions of human biology and health. | Cell Syst | 2022 |
| 34789538 | Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia. | Cancer Discov | 2022 |
| 33382404 | Genetic Risk Score for Serum 25-Hydroxyvitamin D Concentration Helps to Guide Personalized Vitamin D Supplementation in Healthy Finnish Adults. | J Nutr | 2021 |
| 33625756 | The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia. | Am J Hematol | 2021 |
| 33530027 | STRN-ALK rearranged pediatric malignant peritoneal mesothelioma - Functional testing of 527 cancer drugs in patient-derived cancer cells. | Transl Oncol | 2021 |
| 34876631 | FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML. | Sci Rep | 2021 |
| 34515408 | The Porto European Cancer Research Summit 2021. | Mol Oncol | 2021 |
| 34302041 | Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia. | NPJ Precis Oncol | 2021 |
| 33955203 | High tumor cell platelet-derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma. | J Pathol Clin Res | 2021 |
| 31439679 | Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types. | Haematologica | 2020 |
| 31968078 | Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival. | Blood Adv | 2020 |
| 32678289 | KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia. | Leukemia | 2020 |
| 32591764 | Publisher Correction: Building an international consortium for tracking coronavirus health status. | Nat Med | 2020 |
| 32989221 | Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness. | Cell Death Dis | 2020 |
| 32119072 | Breeze: an integrated quality control and data analysis application for high-throughput drug screening. | Bioinformatics | 2020 |
| 30635636 | Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL. | Leukemia | 2019 |
| 30237271 | T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma. | Haematologica | 2019 |
| 30125350 | Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells. | Int J Cancer | 2019 |
| 31269283 | Fibroblast as a critical stromal cell type determining prognosis in prostate cancer. | Prostate | 2019 |
| 31175323 | Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML. | Leukemia | 2019 |
| 30835561 | Individual and stable autoantibody repertoires in healthy individuals. | Autoimmunity | 2019 |
| 30745580 | Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas. | Br J Cancer | 2019 |
| 30358171 | Combined epithelial marker analysis of tumour budding in stage II colorectal cancer. | J Pathol Clin Res | 2019 |
| 30530703 | Anagrelide for Gastrointestinal Stromal Tumor. | Clin Cancer Res | 2019 |
| 30468409 | Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer. | Per Med | 2019 |
| 28804127 | Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. | Leukemia | 2018 |
| 30026337 | PD-L1<sup>+</sup> tumor-associated macrophages and PD-1<sup>+</sup> tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma. | Haematologica | 2018 |
| 29970484 | Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy. | Mol Cancer Ther | 2018 |
| 29900672 | Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer. | Mol Oncol | 2018 |
| 30143015 | Association of tamoxifen resistance and lipid reprogramming in breast cancer. | BMC Cancer | 2018 |
| 29925907 | Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML. | Leukemia | 2018 |
| 29616861 | Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemia. | Leuk Lymphoma | 2018 |